By MICHAEL MILLENSON  Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape. The key, he says, is to avoid being blindsided by the transformational power of digital data. “We’ve been competing against Medtronic and J&J,

By MICHAEL L. MILLENSON  A Trump administration regulation issued just hours before the partial federal shutdown offers quiet hope for civility in government. What happened, on its face, was simple: an update of the rules governing a particular Medicare program. In today’s dyspeptic political climate, however, what didn’t happen along the way was truly remarkable – and may

By MICHAEL L. MILLENSON  A Trump administration regulation issued just hours before the partial federal shutdown offers quiet hope for civility in government. What happened, on its face, was simple: an update ofContinue reading…

By MICHAEL L. MILLENSON  A Trump administration regulation issued just hours before the partial federal shutdown offers quiet hope for civility in government. What happened, on its face, was simple: an update ofContinue reading…

By MICHAEL L. MILLENSON  With nearly 80 percent of internet users searching online for health-related information, it’s no wonder the catchphrase “Dr. Google” has caught on, to the delight of many searchers andContinue reading…

By MICHAEL L. MILLENSON  With nearly 80 percent of internet users searching online for health-related information, it’s no wonder the catchphrase “Dr. Google” has caught on, to the delight of many searchers andContinue reading…

By MICHAEL L. MILLENSON  With nearly 80 percent of internet users searching online for health-related information, it’s no wonder the catchphrase “Dr. Google” has caught on, to the delight of many searchers and the dismay of many real doctors. What’s received little attention from physicians or the public is the company’s quiet metamorphosis into a powerhouse focused on the